Amneal Pharmaceuticals, Inc.

NYSE:AMRX

8.39 (USD) • At close September 6, 2024
Bedrijfsnaam Amneal Pharmaceuticals, Inc.
Symbool AMRX
Munteenheid USD
Prijs 8.39
Beurswaarde 2,597,065,837
Dividendpercentage 0%
52-weken bereik 3.36 - 8.72
Industrie Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Mr. Chirag K. Patel
Website https://www.amneal.com

An error occurred while fetching data.

Over Amneal Pharmaceuticals, Inc.

Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels,

Vergelijkbare Aandelen

Oscar Health, Inc. logo

Oscar Health, Inc.

OSCR

16.99 USD

Brookdale Senior Living Inc. logo

Brookdale Senior Living Inc.

BKD

6.73 USD

Bright Health Group, Inc. logo

Bright Health Group, Inc.

BHG

16.35 USD

Phreesia, Inc. logo

Phreesia, Inc.

PHR

23.55 USD

Cano Health, Inc. logo

Cano Health, Inc.

CANO

2.3 USD

American Well Corporation logo

American Well Corporation

AMWL

7.93 USD

Paragon 28, Inc. logo

Paragon 28, Inc.

FNA

7.3 USD

Invitae Corporation logo

Invitae Corporation

NVTA

0.019 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)